A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
Status:
Completed
Trial end date:
2024-05-05
Target enrollment:
Participant gender:
Summary
The main objectives of this trial are to investigate safety, tolerability, and
pharmacokinetics of BI 1584862 in healthy male subjects following administration of multiple
rising doses.